1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Analysis & Statistics in France, July 2020

Cancer Analysis & Statistics in France, July 2020

1-30 of about 200 reports

2020 France Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • May 2020
  • 585 pages

2020 France Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers ...

  • Cancer
  • France
  • Demand

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted EGFR-NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • France
  • United States

Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted PD-L1 NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • France
  • United States

Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical ...

  • Cancer
  • Lung Cancer
  • Pathology
  • France
  • United Kingdom

BRAF Mutated Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘BRAF Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted BRAF Mutated NSCLC epidemiology ...

  • Cancer
  • Lung Cancer
  • Pathology
  • France
  • Forecast

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Anaplastic lymphoma kinase-Non Small Cell Lung Cancer (ALK-NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted ALK NSCLCepidemiology ...

  • Cancer
  • Lung Cancer
  • Pathology
  • France
  • Germany

2020 France Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities

  • $ 2500
  • April 2020
  • 533 pages

2020 France Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities This new report ...

  • Cancer
  • Pathology
  • France
  • Demand

2020 France Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • April 2020
  • 533 pages

2020 France Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains ...

  • Cancer
  • Pathology
  • France
  • Forecast

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) - Epidemiology Forecast - 2030

  • $ 3750
  • April 2020
  • 72 pages

‘Blastic plasmacytoid dendritic cell neoplasm (BPDCN) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the BPDCN, historical and forecasted epidemiology in the United ...

  • Biopharmaceutical
  • Cancer
  • Cell Therapy
  • Medical Biotechnology
  • France

France Oral Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2025

  • $ 2000
  • February 2020
  • 40 pages

The country research report on France oral cancer treatment market is a customer intelligence and competitive study of the France market. Moreover, the report provides deep insights into demand forecasts, ...

  • Cancer
  • Oropharynx Cancer
  • Pathology
  • France
  • Market Size

2020 France Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 3500
  • February 2020
  • 585 pages

2020 France Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities ...

  • Cancer
  • France
  • Demand

France Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 533 pages

France Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 533 pages, 43 tables, and ...

  • Cancer
  • France

France Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 533 pages

France Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 533 ...

  • Cancer
  • France
  • Forecast

Clinical Laserthermia Systems AB (CLS B) - Product Pipeline Analysis, 2019 Update

  • $ 750
  • October 2019
  • 36 pages

Summary Clinical Laserthermia Systems AB (CLS) is a medical equipment company that develops and markets instruments for the treatment of cancer.The company offers Tranberg, a thermal therapy system developed ...

  • Cancer
  • Hospital
  • France
  • Company
  • Product Initiative

Embolotherapy Market

  • $ 4900
  • September 2019
  • 336 pages

Embolotherapy Market Research Report: By Product (Embolic Agents, Support Devices), Procedure (Transcatheter Arterial Embolization, Transarterial Radioembolization/Selective Internal Radiation Therapy, ...

  • Cancer
  • Pathology
  • France
  • United Kingdom
  • Demand

France Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 4350
  • July 2019
  • 585 pages

France Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities ...

  • Cancer
  • France
  • Demand

France Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

  • $ 2450
  • July 2019
  • 585 pages

France Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023 HighlightsComprehensive ...

  • Cancer
  • France
  • Market Shares

France Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

  • $ 2500
  • May 2019
  • 533 pages

France Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities This new report from ...

  • Cancer
  • Pathology
  • France
  • Demand

France Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • May 2019
  • 533 pages

France Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 533 pages, 43 tables, and presents ...

  • Cancer
  • Pathology
  • France
  • Demand

France Hospital Cancer Diagnostics Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • May 2019
  • 533 pages

France Hospital Cancer Diagnostics Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 533 pages, 43 tables, and presents ...

  • Cancer
  • Pathology
  • France
  • Demand

2019 France Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • April 2019
  • 585 pages

2019 France Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers HighlightsComprehensive 585-page ...

  • Cancer
  • France
  • Market Shares

Hybrigenics SA (ALHYG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 26 pages

Summary Hybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and non-cancerous diseases.Its lead product candidate Inecalcitol, is a ...

  • Cancer
  • Pharmaceutical
  • France
  • Deals & Alliance
  • Hybrigenics SA

Curie Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 35 pages

Summary Curie Institute is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer.The foundation carries out research ...

  • Cancer
  • Pharmaceutical
  • France
  • Company
  • Inserm Transfert SA

OSE Immunotherapeutics (OSE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 47 pages

Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers.The company’s ...

  • Cancer
  • Pharmaceutical
  • France
  • Company
  • Selexis SA

Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 75 pages

Summary Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases.The ...

  • Cancer
  • Healthcare
  • Pharmaceutical
  • France
  • Transgene SA

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • $ 7995
  • September 2018
  • 162 pages

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU Summary Market access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, ...

  • Cancer
  • France
  • Bristol-Myers Squibb Company
  • Novartis AG
  • PROVENGE group

IntegraGen SA (ALINT) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • July 2018
  • 27 pages

Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology.The company provides advanced genomic and bioinformatic services, ...

  • Cancer
  • Lung Cancer
  • France
  • Company Financials
  • IntegraGen

Nanobiotix SA (NANO) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • May 2018
  • 45 pages

Summary Nanobiotix SA (Nanobiotix) is a late stage clinical company which develops nanomedicines for the treatment of cancers.The company develops first-in-class products utilizing its proprietary technology ...

  • Cancer
  • Neck Cancer
  • France
  • Product Initiative
  • Nanobiotix

Institut Curie - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2017
  • 33 pages

Summary Institut Curie is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research ...

  • Cancer
  • Pharmaceutical
  • France
  • Company
  • Inserm Transfert SA

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2025

  • $ 3995
  • November 2017
  • 47 pages

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2025 Summary Chronic lymphocytic leukemia (CLL), also known as chronic lymphoid leukemia, is a type of cancer of the white blood ...

  • Cancer
  • Epidemiology
  • Hospital
  • Leukemia
  • France

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on